Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
93.39
-1.67 (-1.76%)
At close: Oct 23, 2026, 4:00 PM EDT
93.82
+0.43 (0.46%)
After-hours: Oct 23, 2026, 7:30 PM EDT
Insmed Stock Forecast
Stock Price Forecast
According to 24 analysts polled by S&P Global, Insmed stock has a consensus rating of "Strong Buy" and an average price target of $196.14. The average 1-year stock price forecast is 110.02% higher than the current stock price, while the lowest is $165 (+76.68%) and the highest is $243 (+160.20%).
Price Target: $196.14 (+110.02%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Insmed stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 17 | 17 | 18 | 18 | 19 | 18 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 22 | 22 | 23 | 23 | 24 | 24 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Reiterates $218 → $213 | Buy | Reiterates | $218 → $213 | +128.08% | Oct 21, 2026 |
| Roth MKM | Roth MKM | Buy Reiterates $198 | Buy | Reiterates | $198 | +112.01% | Oct 20, 2026 |
| Raymond James | Raymond James | Buy Maintains $187 → $173 | Buy | Maintains | $187 → $173 | +85.24% | Oct 20, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $169 | Buy | Reiterates | $169 | +80.96% | Oct 13, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $192 | Buy | Maintains | $192 | +105.59% | Oct 12, 2026 |
Financial Forecast
Revenue This Year
1.81B
from 606.42M
Increased by 198.18%
Revenue Next Year
2.91B
from 1.81B
Increased by 60.91%
EPS This Year
-1.59
from -6.42
EPS Next Year
0.80
from -1.59
EPS and Forward PE are based on non-GAAP adjusted numbers.